Yahoo India Web Search

Search results

  1. Shiva Pharmachem, headquartered at Vadodara, Gujarat (India), is the largest manufacturer of acid and alkyl chlorides, by volume, in CY 2022 in India and a key player globally. We are an ISO 9001:2015, ISO 14001:2015 and ISO 45001:2018 certified company.

    • About Us

      Shiva Pharmachem, headquartered at Vadodara, Gujarat...

    • Contact

      Shiva Pharmachem AG. Hofackerstrasse 3a 4132 Muttenz,...

    • Products

      Products - Shiva Pharmachem Ltd.

    • Services

      Services - Shiva Pharmachem Ltd.

  2. Sep 23, 2024 · Shiva Pharmachem Limited is an unlisted public company incorporated on 18 March, 1999. It is classified as a public limited company and is located in Vadodara, Gujarat. It's authorized share capital is INR 28.00 cr and the total paid-up capital is INR 21.24 cr.

  3. Shiva Pharmachem Limited is a Public incorporated on 18 March 1999. It is classified as Non-government company and is registered at Registrar of Companies, ROC Ahmedabad. Its authorized share capital is Rs. 280,000,000 and its paid up capital is Rs. 212,406,000.

  4. Shiva Pharmachem, based near Vadodara, Gujarat (India), is a leading manufacturer and global supplier of Acid / Alkyl Chlorides and Other Speciality Intermediates.

  5. Jul 23, 2024 · With over 20 years of experience, Shiva Pharmachem is the largest manufacturer of acid and alkyl chlorides in India and a key player globally. They started with chlorine chemistry and later developed competencies in advanced intermediates. They have three manufacture facilities at in Luna, Dahej SEZ, and Sajóbábony.

    • Book Built Issue IPO
    • Not more than 50% of the Net Issue
    • BSE & NSE
    • Not less than 35% of the Net Issue
  6. Aug 22, 2023 · Speciality chemicals manufacturer Shiva Pharmachem plans to raise ₹ 900 crore from the primary market and has filed preliminary papers for its maiden public issue.

  7. People also ask

  8. Aug 22, 2023 · Vadodara-based Shiva Pharmachem, the largest manufacturer of acid and alkyl chlorides by volume in 2022, has filed its draft red herring prospectus (DRHP) with market regulator Sebi for an IPO. The issue with a face value of Rs 2 each is entirely an offer for sale (OFS) of up to Rs 900 crore by promoter and promoter group selling shareholders.